CNR1 and Hepatic steatosis: Especially CB1 has emerged as a pivotal mediator in liver and exerts profibrogenic effects in chronic liver diseases including hepatic fibrosis, liver cirrhosis alcoholic fatty liver and nonalcoholic fatty liver [44].